Maziar Mike Doustdar is a global business leader known for his long career in the pharmaceutical industry. Born in Iran and raised in the United States, he later moved to Austria to study business and marketing. Over the years, he worked his way up at Novo Nordisk, a major healthcare company, starting as an office clerk and eventually becoming its CEO in August 2025.
Doustdar has spent more than 30 years helping Novo Nordisk grow in international markets. He has lived and worked in many countries, including Turkey, Malaysia, and Switzerland, and speaks English, Farsi, and German. His leadership is known for being people-focused, practical, and driven by a strong sense of purpose. Today, he leads one of the world’s largest pharmaceutical companies, helping millions of patients around the globe.
Early Life and Background
Maziar was born on August 29, 1970, in Iran. His early years were shaped by the culture and traditions of his birthplace, but his life took a major turn when his family moved to the United States. Growing up in America gave Doustdar a new perspective—one that blended Eastern values with Western opportunities. This mix of backgrounds helped him develop a strong sense of adaptability, which would later become a key part of his leadership style.
As a child in the U.S., Doustdar was exposed to a fast-paced, diverse environment. He learned English early and became fluent in it, along with Farsi, his native language. Later in life, he would also become fluent in German. These language skills allowed him to connect with people from different parts of the world, something that proved useful in his global career.
Family and Home
Behind the executive title, Maziar is a husband and father. He lives in Kloten, a town near Zurich in Switzerland, with his wife and younger son. His wife and son are Dutch citizens, adding another layer of international flavor to his family life. His older son is currently studying in Scotland, continuing the family’s tradition of global education.
Doustdar’s family has moved with him across countries and continents. From Turkey to Malaysia to Switzerland, they’ve supported his career while building their own lives. His second son was born in Istanbul during his time managing Novo Nordisk’s operations in Turkey and Syria. These personal milestones are woven into his professional journey, showing how closely his work and family life are connected.
Maziar Mike Doustdar Wiki | BIO
| Attribute | Details |
|---|---|
| Full Name | Maziar Mike Doustdar |
| Date of Birth | August 29, 1970 |
| Age (as of 2025) | 54 Years |
| Birthplace | Iran |
| Nationality | Austrian |
| Hometown | Kloten, Zurich, Switzerland |
| Zodiac Sign | Virgo |
| Religion | Christianity |
| Height | 5’9″ (175 cm) |
| Eye Colour | Light Brown |
| Hair Colour | Bald |
| Languages Spoken | English, Farsi, German |
| Marital Status | Married |
| Children | Two sons (one born in Istanbul, one studying in Scotland) |
| Education | BA in International Business (Marketing), Webster Vienna Private University |
| Executive Education, Harvard Business School (2012) | |
| Profession | Pharmaceutical Executive |
| Known For | CEO of Novo Nordisk (from August 7, 2025) |
| Years Active | 1992–present |
| Previous Roles at Novo Nordisk | Office Clerk, General Manager, VP, SVP, EVP of International Operations |
| Board Memberships | Orion Corporation (Board Member), International Community School (Trustee) |
| Notable Achievements | First non-Danish CEO of Novo Nordisk in 102 years |
| Residence | Switzerland |
| Wikipedia | @Maziar_Mike_Doustdar |
Wife & Kids
Doustdar is married, and his wife is a Dutch citizen. The couple currently resides in Kloten, a quiet town near Zurich, Switzerland. Their home life is rooted in a blend of cultures—Austrian, Dutch, Iranian, and American—mirroring Doustdar’s own multicultural background. While his wife’s name and profession are not publicly disclosed, she has been a steady presence throughout his international career, supporting him through relocations across Europe, the Middle East, and Asia.
Together, they have two sons. Their younger son lives with them in Switzerland and, like his mother, holds Dutch citizenship. Their older son is currently pursuing higher education in Scotland, continuing the family’s tradition of academic excellence and global mobility. Notably, Doustdar’s second son was born in Istanbul during his five-year tenure managing Novo Nordisk’s operations in Turkey and Syria—a period that was both professionally demanding and personally meaningful.
Education and Academic Journey
In 1992, Doustdar enrolled at Webster Vienna Private University in Austria. He chose to study International Business with a focus on Marketing, a decision that would shape his entire career. The university, known for its global outlook and diverse student body, was a perfect fit for someone like Doustdar. He quickly adapted to life in Vienna, learning to navigate a new culture while keeping his eyes on his goals.
During his time at Webster, Doustdar stood out for his curiosity and work ethic. He wasn’t just interested in textbooks—he wanted to understand how business worked in the real world. Doustdar graduated in 1994 with a Bachelor of Arts in International Business. Years later, in 2012, Doustdar returned to school—not for a full degree, but for an executive education program at Harvard Business School. At Harvard, Doustdar studied topics like global healthcare trends, innovation management, and organizational leadership.
Physical Appearance
Maziar stands at approximately 5 feet 9 inches (175 cm). He has light brown eyes and a bald head, which gives him a clean and professional look. While physical appearance isn’t the most important part of a leader’s profile, it does play a role in how people perceive them. Doustdar’s calm and confident presence has made him a respected figure in boardrooms and conferences around the world.
He often dresses in classic business attire—suits, ties, and polished shoes. His style is simple but sharp, reflecting his focus on substance over flash. In interviews and public appearances, he speaks clearly and thoughtfully, often pausing to consider his words. This careful approach has earned him a reputation as someone who listens before he speaks.
Career Beginnings at Novo Nordisk
Maziar Mike began his career at Novo Nordisk in 1992, working as an office clerk in Vienna, Austria. It was a humble start, but one that laid the foundation for everything that followed. At the time, he was still a student at Webster Vienna Private University, studying International Business. The job gave him a chance to learn the basics of the pharmaceutical industry while finishing his degree.
In those early years, Doustdar didn’t just file papers or answer phones. He paid attention to how the company worked—how decisions were made, how teams were structured, and how products moved from labs to patients. By 1993, Doustdar began taking on more responsibilities. Over the next decade, he worked in finance, IT, logistics, operations, and marketing.
See Also:- Elizaveta Krivonogikh Wiki, Height, Age, Boyfriend, Family, Biography
Rise Through the Ranks
After starting as an office clerk in Vienna, Maziar didn’t rush his way to the top. Instead, he built his career slowly, learning from every role and every region. Between 1993 and 2007, he held a wide range of positions at Novo Nordisk. These included roles in finance, IT, logistics, operations, and marketing. Each position gave him a deeper understanding of how the company worked and what it needed to grow.
Doustdar didn’t stay in one place. He moved between offices in Vienna, Athens, and Zurich, gaining experience in different markets. His time in Athens, for example, helped him understand the dynamics of Southern Europe. In Zurich, he got closer to the company’s broader European strategy. By 2007, Doustdar had proven himself as a capable and committed leader.
Global Leadership and Impact
In 2010, Doustdar was promoted to Vice President of the Business Area Near East. This role expanded his responsibilities and gave him more influence over strategy and operations. He spent five years living and working in Turkey, where he managed both the Turkish and Syrian businesses. In 2012, Doustdar relocated to Malaysia. This move signaled a shift in focus toward Southeast Asia and Australasia. He was now responsible for operations in more than 15 countries, including Indonesia, Thailand, Vietnam, Australia, and New Zealand.
By 2013, Doustdar’s impact was clear. He was promoted to Senior Vice President of International Operations, overseeing business in over 150 countries. In April 2015, Doustdar was promoted again, this time to Executive Vice President. In September 2016, his role expanded even further. He now oversaw all global commercial units, except for the USA and Canada. Under his leadership, the company’s international sales more than doubled, reaching approximately 112 billion Danish kroner by 2024.
CEO Appointment at Novo Nordisk
On July 29, 2025, Novo Nordisk made a historic announcement: Maziar Mike Doustdar would become the company’s next CEO, effective August 7, 2025. He would succeed Lars Fruergaard Jørgensen, who had led the company through a period of rapid growth and innovation. Doustdar’s appointment marked a major milestone—not just for him, but for the company. He became the first non-Danish CEO in Novo Nordisk’s 102-year history.
The timing of Doustdar’s appointment was significant. Novo Nordisk was facing a tough market environment. Its share price had dropped, and competition in the diabetes and obesity drug sectors was heating up. The company needed a leader who could navigate uncertainty, rebuild investor confidence, and drive innovation. Doustdar’s deep experience in international markets made him a strong choice.
Board Memberships and External Roles
While Maziar Doustdar’s name is most closely tied to Novo Nordisk, his influence extends beyond the company. In March 2022, he joined the board of Orion Corporation, a global pharmaceutical company based in Finland. His role there includes serving on the Personnel & Remuneration Committee, where he helps shape policies around leadership compensation and employee development. As of December 2024, Doustdar held 1,511 Orion B-shares, reflecting both his commitment and investment in the company’s future.
Doustdar also serves on the Board of Trustees for the International Community School in Zurich. This role speaks to his interest in education and community engagement. The school is known for its diverse student body and global curriculum, making it a fitting place for someone with Doustdar’s international background. From 2017 to 2021, Doustdar chaired the Patient Access Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Contributions to Global Pharma
Doustdar’s impact on the pharmaceutical industry goes far beyond titles and promotions. He has played a key role in expanding access to life-saving medicines in regions that are often overlooked by major companies. Under his leadership, Novo Nordisk’s international operations grew rapidly, reaching 35 million patients and generating over 112 billion DKK in sales by 2024. These numbers reflect not just business success but real-world impact.
He has worked closely with governments, healthcare providers, and local communities to improve delivery systems and reduce barriers to treatment. In Southeast Asia, for example, Doustdar helped establish partnerships that made diabetes care more affordable and widely available. In the Middle East, he navigated complex political environments to ensure patients could still receive essential medications.
Lesser-Known Facts
- Doustdar is fluent in English, Farsi, and German.
- He grew up in the United States before moving to Austria at age 22.
- His second son was born in Istanbul during his time managing operations in Turkey.
- He currently lives in Kloten, Zurich, Switzerland.
- He holds shares in Orion Corporation and serves on its board.
- He served as chairperson of EFPIA’s Patient Access Committee from 2017 to 2021.
Read Also:- Tyrese Haliburton Weight, Height, Age, Girlfriend, Family, Biography
